US equities
|
MU
$1,029.00
▼-0.66%
NVDA
$229.28
▼-0.52%
SPCX
$162.57
▲+1.25%
TSLA
$382.70
▲+2.05%
AAPL
$336.64
▼-1.11%
MSFT
$535.07
▲+2.38%
AMZN
$262.43
▲+3.29%
META
$718.67
▼-0.31%
MU
$1,029.00
▼-0.66%
NVDA
$229.28
▼-0.52%
SPCX
$162.57
▲+1.25%
TSLA
$382.70
▲+2.05%
AAPL
$336.64
▼-1.11%
MSFT
$535.07
▲+2.38%
AMZN
$262.43
▲+3.29%
META
$718.67
▼-0.31%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Jim Wilson
Recent news which mentions Jim Wilson
Center for Breakthrough Medicines signs $100M collaboration deal with Penn's gene therapy program
January 18, 2022
Tags
Audrey Greenberg
Colleges & Universities
Joerg Ahlgrimm
From
Business Journals
Roseville wealth advisory firm Capital Planning Advisors acquired by growing Texas company
December 09, 2021
Tags
Banking & Financial Services
Capital Planning Advisors
Jim Wilson
From
Business Journals
Amicus Therapeutics spins off genetic medicine unit in $600M SPAC deal
September 29, 2021
Tags
Amicus Therapeutics
Amicus Therapeutics Inc/
Adam Stone
From
Business Journals